18-Feb-2026
No headlines found.
No press releases found.
No news found.
The Fund seeks daily investment results, before fees and expenses, of 300% of the performance of the S&P Biotechnology Select Industry Index. The Index is provided by Standard & Poor s and includes domestic companies from the biotechnology industry. As of April 30, 2015, the Index was comprised of 98 stocks. The companies included in the Index have a median market capitalization of $1.54 billion and are concentrated in the energy and biotechnology sectors as of April 30, 2015.
Direxion Daily S&P Biotech Bull 3X trades on the ARCA stock market under the symbol LABU.
As of February 18, 2026, LABU stock price climbed to $166.70 with 310,651 million shares trading.
LABU has a beta of 2.82, meaning it tends to be more sensitive to market movements. LABU has a correlation of 0.38 to the broad based SPY ETF.
LABU has a market cap of $570.86 million. This is considered a Small Cap stock.
In the last 3 years, LABU traded as high as $198.18 and as low as $32.55.
LABU has outperformed the market in the last year with a return of +85.3%, while the SPY ETF gained +13.8%. In the last 3 month period, LABU beat the market returning +23.3%, while SPY returned +3.4%. However, in the most recent 2 weeks LABU has underperformed the stock market by returning -6.0%, while SPY returned -0.5%.
LABU support price is $152.33 and resistance is $171.81 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LABU shares will trade within this expected range on the day.
